In a study on disseminated Staphylococcus in children, MRSA was the causative agent in all cases. Children aged 5 to 12 years were most vulnerable, and trauma was found to be a common precipitating factor. 2 Septic vasculitis caused by septicemia from Staphylococci is an immune-complex negative, small-vessel neutrophilic vasculitis. 3 Clinical lesions of septic vasculitis are characterized by retiform purpura, petechiae and ecchymoses, vesiculopustules, hemorrhagic bullae, and ulceration. 4 In cases of septic emboli without evidence of vasculitis, some prefer the term septic vasculopathy. One study 5 compared 32 patients with bacterial sepsis, cutaneous lesions, and biopsy-proven septic vasculopathy. Cutaneous lesions were an early finding of sepsis in most patients (91%; n = 29). Most cases (n = 18) involved the development of lesions simultaneously or within the first 24 hours of sepsis that were disseminated rather than localized. Most lesions presented as purpuric papules and plaques, followed by petechiae, vesicles and bullae, pustules, distal ischemia, and nodules. 4 Septic vasculopathy had a mortality rate of 20% in this study, 5 making early recognition and treatment essential. In addition to cutaneous findings, staphylococcal sepsis can involve the lung, heart, kidneys, brain, bone, and joints, 6 and it is important to evaluate for these potential sites of involvement. As this case report highlights, consulting dermatologists can play a role in identifying disseminated infections by recognizing the diverse skin manifestations and performing appropriate biopsies for analysis by frozen section, permanent section, and tissue culture. Drugs common in the treatment of acne vulgaris, such as minocycline and isotretinoin, have been reported in association with pseudotumor cerebri (PTC), which can lead to severe, irreversible symptoms, including vision loss. There is a paucity of data on isotretinoin use in patients with prior PTC.
Report of Cases | Case 1. A female patient in her teens presented with a 2-year history of severe, nodular, cystic acne of her face ( Figure 1A) , chest, and back with significant scarring. Her hormonal workup was unrevealing. Two years earlier, she had received minocycline for acne and had developed an unusually severe headache; lumbar puncture confirmed PTC. Prompt discontinuation of minocycline treatment led to longterm PTC symptom resolution. However, her acne was recalcitrant to treatment for several months with oral contraceptives, spironolactone (200 mg/d), topical antibiotics, and topical retinoids; she also required frequent intralesional triamcinolone for persistent painful cysts. Isotretinoin therapy was initiated at 10 mg/d for 7 days, and the dose was increased slowly over 4 months to 40 mg/d; the patient noted skin dryness and facial erythema but developed no signs or symptoms concerning for PTC. After 9 months of isotretinoin therapy (cumulative dose, 120 mg/kg), her acne had markedly improved ( Figure 1B) .
Case 2.
A woman in her late 20s presented with polycystic ovarian syndrome, severe inflammatory nodular acne with scarring (Figure 2A) , and a history of minocycline-associated PTC (diagnosed at age 16 years via lumbar puncture). Her acne had not responded adequately to several topical retinoids at maximum concentrations, concomitant benzoyl peroxide, topical and oral antibiotics, spironolactone, and oral contraceptives. Multiple clinicians had avoided isotretinoin use given her history of PTC.
Owing to the recalcitrance of her acne to combination therapy with several agents, low-dose isotretinoin therapy was begun (initiated at 10 mg/d), and the dose gradually increased to therapeutic levels (cumulative dose, 140 mg/kg over 7 months of treatment). She experienced dramatic acne improvement with only mild residual scarring ( Figure 2B ). The only adverse effects were skin dryness and hypertriglyceridemia, both of which resolved after isotretinoin therapy was completed.
Case 3.
A female patient in her teens presented with severe scarring, nodular acne and a history of PTC (confirmed by ophthalmologic and neurologic evaluation) that had developed after she had started isotretinoin therapy 3 years earlier. Her PTC resolved at that time with discontinuation of isotretinoin therapy. As with patient 2, her acne did not respond adequately to several topical retinoids at maximum concentrations, concomitant benzoyl peroxide, topical and oral antibiotics, spironolactone, and oral contraceptives. And again, as with patient 2, multiple clinicians had avoided isotretinoin use given her history of PTC.
Low-dose isotretinoin therapy was begun (initiated at 30 mg/d), and the dose increased gradually to therapeutic levels (cumulative dose, 120 mg/kg over 9 months of treatment). Owing to her history of isotretinoin-associated PTC, an initial neurology consultation and monthly ophthalmology examinations were performed throughout the isotretinoin treatment period. She experienced dramatic acne improvement with only mild residual scarring. The only adverse effect was skin dryness, which resolved after isotretinoin therapy was completed.
Discussion | Pseudotumor cerebri is characterized by symptoms of increased intracranial pressure: headache, visual disturbances (blurry vision, diplopia), nausea and vomiting, and stiff neck. 1 It is commonly idiopathic, primarily affecting women of childbearing age who are overweight. Less frequently, it can occur in association with other disease conditions (usually endocrinologic abnormalities such as polycystic ovarian syndrome). 2 Despite many anecdotal reports of drug-associated PTC, there are 4 primary drug classes that are considered by experts to have a true association with PTC 1,3 : (1) tetracyclines, including doxycycline and minocycline; (2) oral retinoids; (3) recombinant growth hormone; and (4) corticosteroids (following withdrawal). Cross-reactivity between these drug classes in patients with drug-associated PTC has not been reported. Symptoms usually regress completely after discontinuation of the drug therapy.
The pathophysiological mechanisms of drug-associated PTC are not fully understood. It has been postulated that tetracyclines may reduce cerebrospinal fluid outflow at the arachnoid villi, while oral retinoids (through excess retinols and retinol-binding protein) may be directly toxic to arachnoid villi function. 5, 6 We report safe use of isotretinoin in 3 patients with histories of drug-associated PTC. When acne warrants isotretinoin treatment, a patient history of PTC should not preclude its use if careful surveillance for PTC recurrence can be conducted. Baseline evaluation by ophthalmology and/or neurology services should be considered.
